Clinical Trial Update: Methylated Biomarkers Predictive of Endometrial Cancer Risk

View source ↗

Summary

A clinical trial update from the University of Manchester describes methylated biomarkers that may predict endometrial cancer risk. The study is currently activ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Endometrial Cancer

Snippet

Sponsor: University of Manchester | Conditions: Endometrial Cancer | Status: ACTIVE_NOT_RECRUITING